SEARCH

SEARCH BY CITATION

References

  • Asplin, K.E., Sillence, M.N., Pollitt, C.C. and McGowan, C.M. (2007) Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Aust. vet. J. 174, 530-535.
  • Bailey, S.R., Habershon-Butcher, J.L., Ransom, K.J., Elliott, J. and Menzies-Gow, N.J. (2008) Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis. Am. J. vet. Res. 69, 122-129.
  • Baykan, M., Erem, C., Gedikli, O., Hacihasanoglu, A., Erdogan, T., Kocak, M., Durmus, I., Korkmaz, L. and Celik, S. (2007) Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's Syndrome. Endocrine 31, 300-304.
  • Beech, J., Boston, R., Lindborg, S. and Russell, G.E. (2007) Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia. J. Am. vet. med. Ass. 231, 417-426.
  • Buren, J., Liu, H.X., Jensen, J. and Eriksson, J.W. (2002) Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur. J. Endocrinol. 146, 419-429.
  • Carter, R.A., Geor, R.J., Burton Staniar, W., Cubitt, T.A. and Harris, P.A. (2009a) Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies. Aust. vet. J. 179, 204-210.
  • Carter, R.A., McCutcheon, L.J., George, L.A., Smith, T.L., Frank, N. and Geor, R.J. (2009b) Effects of diet-induced weight gain on insulin sensitivity and plasma hormone and lipid concentrations in horses. Am. J. vet. Res. 70, 1250-1258.
  • Carter, R.A., McCutcheon, L.J., Valle, E., Meilahn, E.N. and Geor, R.J. (2010) Effects of exercise training on adiposity, insulin sensitivity, and plasma hormone and lipid concentrations in overweight or obese, insulin-resistant horses. Am. J. vet. Res. 71, 314-321.
  • Carter, R.A., Treiber, K.H., Geor, R.J., Douglass, L. and Harris, P.A. (2009c) Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies. Equine vet. J. 41, 171-178.
  • de Laat, M.A., McGowan, C.M., Sillence, M.N. and Pollitt, C.C. (2010) Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses. Equine vet. J. 42, 129-135.
  • Donaldson, M.T., Jorgensen, A.J. and Beech, J. (2004) Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J. Am. vet. med. Ass. 224, 1123-1127.
  • Donaldson, M.T., LaMonte, B.H., Morresey, P., Smith, G. and Beech, J. (2002) Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease). J. vet. Intern. Med. 16, 742-746.
  • Donaldson, M.T., McDonnell, S.M., Schanbacher, B.J., Lamb, S.V., McFarlane, D. and Beech, J. (2005) Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses. J. vet. Intern. Med. 19, 217-222.
  • Durham, A.E., Rendle, D.I. and Newton, J.E. (2008) The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance. Equine vet. J. 40, 493-500.
  • Durham, A.E., Hughes, K.J., Cottle, H.J., Rendle, D.I. and Boston, R.C. (2009) Type 2 diabetes mellitus with pancreatic β cell dysfunction in 3 horses confirmed with minimal model analysis. Equine vet. J. 41, 924-929.
  • Dybdal, N.O., Hargreaves, K.M., Madigan, J.E., Gribble, D.H., Kennedy, P.C. and Stabenfeldt, G.H. (1994) Diagnostic testing for pituitary pars intermedia dysfunction in horses. J. Am. vet. med. Ass. 204, 627-632.
  • Eades, S.C., Stokes, A.M., Johnson, P.J., Leblanc, C.J., Ganjam, V.K., Buff, P.R. and Moore, R.M. (2007) Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin, and glucose in blood obtained from horses following carbohydrate overload. Am. J. vet. Res. 68, 87-94.
  • Eiler, H., Frank, N., Andrews, F.M., Oliver, J.W. and Fecteau, K.A. (2005) Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses. Am. J. vet. Res. 66, 1598-1604.
  • Fernandez-Sanchez, A., Madrigal-Santillan, E., Bautista, M., Esquivel-Soto, J., Morales-Gonzalez, A., Esquivel-Chirino, C., Durante-Montiel, I., Sanchez-Rivera, G., Valadez-Vega, C. and Morales-Gonzalez, J.A. (2011) Inflammation, oxidative stress, and obesity. Int. J. Mol. Sci. 12, 3117-3132.
  • Frank, N. (2009) Equine Metabolic Syndrome. J. equine vet. Sci. 29, 259-265.
  • Frank, N., Buchanan, B.R. and Elliott, S.B. (2008a) Effects of long-term oral administration of levothyroxine sodium on serum thyroid hormone concentrations, clinicopathologic variables, and echocardiographic measurements in healthy adult horses. Am. J. vet. Res. 69, 68-75.
  • Frank, N., Elliott, S.B. and Boston, R.C. (2008b) Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses. Am. J. vet. Res. 69, 76-81.
  • Frank, N., Elliott, S.B., Brandt, L.E. and Keisler, D.H. (2006) Physical characteristics, blood hormone concentrations, and plasma lipid concentrations in obese horses with insulin resistance. J. Am. vet. med. Ass. 228, 1383-1390.
  • Frank, N., Elliott, S.B., Chameroy, K.A., Toth, F., Chumbler, N.S. and McClamroch, R. (2010a) Association of season and pasture grazing with blood hormone and metabolite concentrations in horses with presumed pituitary pars intermedia dysfunction. J. vet. Intern. Med. 24, 1167-1175.
  • Frank, N., Elliott, S.B., Chameroy, K.A., Toth, F., Chumbler, N.S. and McClamroch, R. (2010b) Association of season and pasture grazing with blood hormone and metabolite concentrations in horses with presumed pituitary pars intermedia dysfunction. J. vet. Intern. Med. 24, 1167-1175.
  • Frank, N., Geor, R.J., Bailey, S.R., Durham, A.E. and Johnson, P.J. (2010c) Equine metabolic syndrome. J. vet. Intern. Med. 24, 467-475.
  • Freestone, J.F., Beadle, R., Shoemaker, K., Bessin, R.T., Wolfsheimer, K.J. and Church, C. (1992) Improved insulin sensitivity in hyperinsulinaemic ponies through physical conditioning and controlled feed intake. Equine vet. J. 24, 187-190.
  • Geor, R.J. and Harris, P. (2009) Dietary management of obesity and insulin resistance: countering risk for laminitis. Vet. Clin. N. Am.: Equine Pract. 25, 51-65.
  • Geor, R.J., Hinchcliff, K.W., McCutcheon, L.J. and Sams, R.A. (2000) Epinephrine inhibits exogenous glucose utilization in exercising horses. J. appl. Physiol. 88, 1777-1790.
  • Haritou, S.J., Zylstra, R., Ralli, C., Turner, S. and Tortonese, D.J. (2008) Seasonal changes in circadian peripheral plasma concentrations of melatonin, serotonin, dopamine and cortisol in aged horses with Cushing's disease under natural photoperiod. J. Neuroendocrinol. 20, 988-996.
  • Hartge, M.M., Unger, T. and Kintscher, U. (2007) The endothelium and vascular inflammation in diabetes. Diab. Vasc. Dis. Res. 4, 84-88.
  • Hoffman, R.M., Boston, R.C., Stefanovski, D., Kronfeld, D.S. and Harris, P.A. (2003) Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J. anim. Sci. 81, 2333-2342.
  • Hustace, J.L., Firshman, A.M. and Mata, J.E. (2009) Pharmacokinetics and bioavailability of metformin in horses. Am. J. vet. Res. 70, 665-668.
  • Johnson, P.J., Slight, S.H., Ganjam, V.K. and Kreeger, J.M. (2002) Glucocorticoids and laminitis in the horse. Vet. Clin. N. Am.: Equine Pract. 18, 219-236.
  • Kahan, V., Andersen, M.L., Tomimori, J. and Tufik, S. (2009) Stress, immunity and skin collagen integrity: evidence from animal models and clinical conditions. Brain Behav. Immun. 23, 1089-1095.
  • Kahn, C.R. (1978) Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27, 1893-1902.
  • Kearns, C.F., McKeever, K.H., Roegner, V., Brady, S.M. and Malinowski, K. (2006) Adiponectin and leptin are related to fat mass in horses. Aust. vet. J. 172, 460-465.
  • Kim, J.A., Montagnani, M., Koh, K.K. and Quon, M.J. (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888-1904.
  • Kim, Y.D., Park, K.G., Lee, Y.S., Park, Y.Y., Kim, D.K., Nedumaran, B., Jang, W.G., Cho, W.J., Ha, J., Lee, I.K., Lee, C.H. and Choi, H.S. (2008) Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57, 306-314.
  • Longland, A.C., Barfoot, C. and Harris, P.A. (2009) The loss of water-soluble carbohydrate and soluble protein from nine different hays soaked in water for up to 16 hours. J. equine vet. Sci. 29, 383-384.
  • Marik, P.E. and Raghavan, M. (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 30, 748-756.
  • McFarlane, D. (2007) Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease. Ageing Res. Rev. 6, 54-63.
  • McFarlane, D. (2011) Equine pituitary pars intermedia dysfunction. Vet. Clin. N. Am.: Equine Pract. 27, 93-113.
  • McFarlane, D. and Holbrook, T.C. (2008) Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction. J. vet. Intern. Med. 22, 436-442.
  • McFarlane, D., Donaldson, M.T., McDonnell, S.M. and Cribb, A.E. (2004) Effects of season and sample handling on measurement of plasma alpha-melanocyte-stimulating hormone concentrations in horses and ponies. Am. J. vet. Res. 65, 1463-1468.
  • McFarlane, D., Miller, L.M., Craig, L.E., Dybdal, N.O., Habecker, P.L., Miller, M.A., Patterson, J.S. and Cribb, A.E. (2005) Agreement in histologic assessments of the pituitary pars intermedia in aged horses. Am. J. vet. Res. 66, 2055-2059.
  • McGowan, C.M. and Neiger, R. (2003) Efficacy of trilostane for the treatment of equine Cushing's syndrome. Equine vet. J. 35, 414-418.
  • McGowan, C.M., Frost, R., Pfeiffer, D.U. and Neiger, R. (2004) Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine vet. J. 36, 295-298.
  • Miller, M.A., Pardo, I.D., Jackson, L.P., Moore, G.E. and Sojka, J.E. (2008) Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction. Vet. Pathol. 45, 26-38.
  • Muniyappa, R., Iantorno, M. and Quon, M.J. (2008) An integrated view of insulin resistance and endothelial dysfunction. Endocrinol. Metab. Clin. North Am. 37, 685-711. ix-x.
  • Muniyappa, R., Montagnani, M., Koh, K.K. and Quon, M.J. (2007) Cardiovascular actions of insulin. Endocr. Rev. 28, 463-491.
  • Musi, N., Hirshman, M.F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J.M., Ljunqvist, O., Efendic, S., Moller, D.E., Thorell, A. and Goodyear, L. (2002) Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074-2081.
  • Perkins, G.A., Lamb, S., Erb, H.N., Schanbacher, B., Nydam, D.V. and Divers, T.J. (2002) Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. Equine vet. J. 34, 679-685.
  • Radin, M.J., Sharkey, L.C. and Holycross, B.J. (2009) Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses. Vet. Clin. Pathol. 38, 136-156.
  • Ralston, S.L. (2002) Insulin and glucose regulation. Vet. Clin. N. Am.: Equine Pract. 18, 295-304. vii.
  • Reeves, H.J., Lees, R. and McGowan, C.M. (2001) Measurement of basal serum insulin concentration in the diagnosis of Cushing's disease in ponies. Vet. Rec. 149, 449-452.
  • Ritchie, S.A., Ewart, M.A., Perry, C.G., Connell, J.M. and Salt, I.P. (2004) The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin. Sci. (Lond). 107, 519-532.
  • Rizzoni, D., Porteri, E., De Ciuceis, C., Rodella, L.F., Paiardi, S., Rizzardi, N., Platto, C., Boari, G.E., Pilu, A., Tiberio, G.A., Giulini, S.M., Favero, G., Rezzani, R., Rosei, C.A., Bulgari, G., Avanzi, D. and Rosei, E. (2009) Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 94, 5010-5018.
  • Ruzzin, J., Wagman, A.S. and Jensen, J. (2005) Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 48, 2119-2130.
  • Saeedi, R., Parsons, H.L., Wambolt, R.B., Paulson, K., Sharma, V., Dyck, J.R., Brownsey, R.W. and Allard, M.F. (2008) Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms. Am. J. Physiol. Heart Circ. Physiol. 294, H2497-H2506.
  • Saland, L.C. (2001) The mammalian pituitary intermediate lobe: an update on innervation and regulation. Brain Res. Bull. 54, 587-593.
  • Schott, H.C. (2006) Pituitary pars intermedia dysfunction: challenges of diagnosis and treatment. Proc. Am. Ass. equine Practnrs . 52, 60-73.
  • Schott, H.C., 2nd (2002) Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet. Clin. N. Am.: Equine Pract. 18, 237-270.
  • Sommardahl, C.S., Frank, N., Elliott, S.B., Webb, L.L., Refsal, K.R., Denhart, J.W. and Thompson, D.L., Jr (2005) Effects of oral administration of levothyroxine sodium on serum concentrations of thyroid gland hormones and responses to injections of thyrotropin-releasing hormone in healthy adult mares. Am. J. vet. Res. 66, 1025-1031.
  • Tiley, H.A., Geor, R.J. and McCutcheon, L.J. (2007) Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses. Am. J. vet. Res. 68, 753-759.
  • Tiley, H.A., Geor, R.J. and McCutcheon, L.J. (2008) Effects of dexamethasone administration on insulin resistance and components of insulin signaling and glucose metabolism in equine skeletal muscle. Am. J. vet. Res. 69, 51-58.
  • Tinworth, K.D., Edwards, S., Noble, G.K., Harris, P.A., Sillence, M.N. and Hackett, L.P. (2010) Pharmacokinetics of metformin after enteral administration in insulin-resistant ponies. Am. J. vet. Res. 71, 1201-1206.
  • Tinworth, K.D., Boston, R.C., Harris, P.A., Sillence, M.N., Raidal, S.L. and Noble, G.K. (2011) The effect of oral metformin on insulin sensitivity in insulin-resistant ponies. Vet. J. Epub ahead of print; doi:10.1016/j.tvjl.2011.01.015.
  • Tóth, F., Frank, N., Geor, R.J. and Boston, R.C. (2010) Effects of pretreatment with dexamethasone or levothyroxine sodium on endotoxin-induced alterations in glucose and insulin dynamics in horses. Am. J. vet. Res. 71, 60-68.
  • Treiber, K., Carter, R., Gay, L., Williams, C. and Geor, R. (2009) Inflammatory and redox status of ponies with a history of pasture-associated laminitis. Vet. Immunol. Immunopathol. 129, 216-220.
  • Treiber, K.H., Kronfeld, D.S., Hess, T.M., Boston, R.C. and Harris, P.A. (2005) Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am. J. vet. Res. 66, 2114-2121.
  • Treiber, K.H., Kronfeld, D.S., Hess, T.M., Byrd, B.M., Splan, R.K. and Staniar, W.B. (2006) Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J. Am. vet. med. Ass. 228, 1538-1545.
  • van der Kolk, J.H., Heinrichs, M., van Amerongen, J.D., Stooker, R.C., in de Wal, L.J. and van den Ingh, T.S. (2004) Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma. Am. J. vet. Res. 65, 1701-1707.
  • Vick, M.M., Adams, A.A., Murphy, B.A., Sessions, D.R., Horohov, D.W., Cook, R.F., Shelton, B.J. and Fitzgerald, B.P. (2007) Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J. anim. Sci. 85, 1144-1155.
  • Vick, M.M., Sessions, D.R., Murphy, B.A., Kennedy, E.L., Reedy, S.E. and Fitzgerald, B.P. (2006) Obesity is associated with altered metabolic and reproductive activity in the mare: effects of metformin on insulin sensitivity and reproductive cyclicity. Reprod. Fertil. Dev. 18, 609-617.
  • Waller, A.P., Burns, T.A., Mudge, M.C., Belknap, J.K. and Lacombe, V.A. (2011a) Insulin resistance selectively alters cell-surface glucose transporters but not their total protein expression in equine skeletal muscle. J. vet. Intern. Med. 25, 315-321.
  • Waller, A.P., Kohler, K., Burns, T.A., Mudge, M.C., Belknap, J.K. and Lacombe, V.A. (2011b) Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissue without change in AS160 activation. Biochim. Biophys. Acta 1812, 1098-1103.
  • Yamagishi, S. (2009) Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications. Ther. Apher. Dial. 13, 534-539.